Search Results

You are looking at 1 - 1 of 1 items for :

  • "programming" x
  • Refine by access: All content x
Clear All
Jonathan D Douros Novo Nordisk Research Center Indianapolis, Indianapolis, Indiana, USA

Search for other papers by Jonathan D Douros in
Google Scholar
PubMed
Close
,
Jacek Mokrosinski Novo Nordisk Research Center Indianapolis, Indianapolis, Indiana, USA

Search for other papers by Jacek Mokrosinski in
Google Scholar
PubMed
Close
, and
Brian Finan Novo Nordisk Research Center Indianapolis, Indianapolis, Indiana, USA

Search for other papers by Brian Finan in
Google Scholar
PubMed
Close

. 2020 ). Academic and industrial GLP-1R agonist programs have since undertaken a robust, iterative approach to optimizing Ex-4-based compounds, including some that demonstrate substantial signaling bias. As mentioned previously, Phe1-Ex-4 exhibits

Restricted access